BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.7B
AUM Growth
-$908M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
107
New
Increased
Reduced
Closed

Top Buys

1
+$66.6M
2
+$56.3M
3
+$29.4M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$26.7M
5
HRTX icon
Heron Therapeutics
HRTX
+$18.6M

Top Sells

1
+$195M
2
+$97.2M
3
+$68.7M
4
GHDX
Genomic Health, Inc.
GHDX
+$54.6M
5
ARRY
Array Biopharma Inc
ARRY
+$46M

Sector Composition

1 Healthcare 94.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$3.46B 23.55%
50,057,277
-992,483
2
$2.72B 18.46%
31,976,193
-2,295,634
3
$1.46B 9.92%
11,777,285
-182,539
4
$1.08B 7.35%
8,258,068
-300,000
5
$1.05B 7.14%
39,292,086
-421,756
6
$806M 5.47%
2,077,214
-83,309
7
$650M 4.42%
7,589,294
8
$539M 3.66%
9,260,922
-938,021
9
$390M 2.65%
3,390,270
10
$259M 1.76%
2,513,462
11
$144M 0.98%
1,019,557
12
$132M 0.9%
2,848,567
-993,722
13
$123M 0.83%
1,169,278
14
$119M 0.81%
1,415,283
+316,613
15
$112M 0.76%
6,018,104
+1,000,000
16
$107M 0.73%
9,145,115
17
$91.7M 0.62%
3,902,421
18
$77.7M 0.53%
1,969,905
+166,667
19
$77M 0.52%
751,927
20
$66.6M 0.45%
+3,532,760
21
$63.9M 0.43%
370,845
-57,500
22
$63M 0.43%
2,462,216
+384,615
23
$60.4M 0.41%
10,749,937
24
$59.6M 0.4%
2,708,200
25
$59.3M 0.4%
1,787,807
1
2 3 4 5